-
Je něco špatně v tomto záznamu ?
PLGA based film forming systems for superficial fungal infections treatment
E. Šnejdrová, J. Martiška, J. Loskot, G. Paraskevopoulos, A. Kováčik, G. Regdon, M. Budai-Szűcs, K. Palát, K. Konečná
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- antifungální látky MeSH
- lidé MeSH
- mykózy * MeSH
- nosiče léků * MeSH
- terbinafin MeSH
- uvolňování léčiv MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
As proven in clinical trials, superficial fungal infections can be effectively treated by single topical application of terbinafine hydrochloride (Ter-HCl) in a film forming system (FFS). Poly(lactic-co-glycolic acid) (PLGA) derivatives, originally synthesized with intention to get carriers with optimized properties for drug delivery, and multifunctional plasticizers - ethyl pyruvate, methyl salicylate, or triacetin - were used for formulation of Ter-HCl loaded FFSs. After spraying, a biodegradable, transparent, adhesive, and occlusive thin layer is formed on the skin, representing drug depot. In situ formed films were characterized by thermal, structural, viscoelastic, and antifungal properties as well as drug release and skin penetration. DSC and SEM showed fully amorphous films with Ter-HCl dissolved in PLGA in high concentration (up to 15%). FFSs are viscoelastic fluids with viscosity which can be easily adjusted by the type of plasticizer used and its concentration. The formulations showed excellent bioadhesion properties, thus ensuring persistence on the skin. In situ film based on branched PLGA/A plasticized with 10% of ethyl pyruvate allowed prolonged release of Ter-HCl by linear kinetics for the first 6 days with a total time of almost 14 days. During ex vivo human skin penetration experiment, Ter-HCl was found to be located only in its target layer, the epidermis. According to our results, plasticized branched PLGA derivatives loaded by Ter-HCl are suitable for the development of FFSs for superficial fungal infections treatment.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21018381
- 003
- CZ-PrNML
- 005
- 20210830095950.0
- 007
- ta
- 008
- 210728s2021 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejps.2021.105855 $2 doi
- 035 __
- $a (PubMed)33872699
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Šnejdrová, Eva $u Department of Pharmaceutical Technology, Charles University, Faculty of Pharmacy in Hradec Kralove, Akademika Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic
- 245 10
- $a PLGA based film forming systems for superficial fungal infections treatment / $c E. Šnejdrová, J. Martiška, J. Loskot, G. Paraskevopoulos, A. Kováčik, G. Regdon, M. Budai-Szűcs, K. Palát, K. Konečná
- 520 9_
- $a As proven in clinical trials, superficial fungal infections can be effectively treated by single topical application of terbinafine hydrochloride (Ter-HCl) in a film forming system (FFS). Poly(lactic-co-glycolic acid) (PLGA) derivatives, originally synthesized with intention to get carriers with optimized properties for drug delivery, and multifunctional plasticizers - ethyl pyruvate, methyl salicylate, or triacetin - were used for formulation of Ter-HCl loaded FFSs. After spraying, a biodegradable, transparent, adhesive, and occlusive thin layer is formed on the skin, representing drug depot. In situ formed films were characterized by thermal, structural, viscoelastic, and antifungal properties as well as drug release and skin penetration. DSC and SEM showed fully amorphous films with Ter-HCl dissolved in PLGA in high concentration (up to 15%). FFSs are viscoelastic fluids with viscosity which can be easily adjusted by the type of plasticizer used and its concentration. The formulations showed excellent bioadhesion properties, thus ensuring persistence on the skin. In situ film based on branched PLGA/A plasticized with 10% of ethyl pyruvate allowed prolonged release of Ter-HCl by linear kinetics for the first 6 days with a total time of almost 14 days. During ex vivo human skin penetration experiment, Ter-HCl was found to be located only in its target layer, the epidermis. According to our results, plasticized branched PLGA derivatives loaded by Ter-HCl are suitable for the development of FFSs for superficial fungal infections treatment.
- 650 _2
- $a antifungální látky $7 D000935
- 650 12
- $a nosiče léků $7 D004337
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a mykózy $7 D009181
- 650 _2
- $a terbinafin $7 D000077291
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Martiška, Juraj $u Department of Pharmaceutical Technology, Charles University, Faculty of Pharmacy in Hradec Kralove, Akademika Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic; InStar Technologies a.s., Mrstikova 399/2a, 460 07 Liberec, Czech Republic. Electronic address: martiska@instar.tech
- 700 1_
- $a Loskot, Jan $u Department of Physics, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, Hradec Kralove 500 03, Czech Republic
- 700 1_
- $a Paraskevopoulos, Georgios $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Kralove, Akademika Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic
- 700 1_
- $a Kováčik, Andrej $u Skin Barrier Research Group, Charles University, Faculty of Pharmacy in Hradec Kralove, Akademika Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic
- 700 1_
- $a Regdon, Géza $u Institute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary
- 700 1_
- $a Budai-Szűcs, Mária $u Institute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary
- 700 1_
- $a Palát, Karel $u Department of Organic And Bioorganic Chemistry, Charles University, Faculty of Pharmacy in Hradec Kralove, Akademika Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic
- 700 1_
- $a Konečná, Klára $u Department of Biological and Medical Sciences, Charles University, Faculty of Pharmacy in Hradec Kralove, Akademika Heyrovskeho 1203, Hradec Kralove 500 05, Czech Republic
- 773 0_
- $w MED00001639 $t European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences $x 1879-0720 $g Roč. 163, č. - (2021), s. 105855
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33872699 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830095951 $b ABA008
- 999 __
- $a ok $b bmc $g 1689492 $s 1138825
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 163 $c - $d 105855 $e 20210416 $i 1879-0720 $m European journal of pharmaceutical sciences $n Eur. j. pharm. sci. (Print) $x MED00001639
- LZP __
- $a Pubmed-20210728